A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of age
Article in Human Vaccines & Immunotherapeutics (August 2023)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in Human Vaccines & Immunotherapeutics (August 2023)
Article in Epidemiology and Infection (December 2022)
Article in PULMONOLOGIYA (December 2022)